Cutler Group LP Acurx Pharmaceuticals, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 1,200 shares of ACXP stock, worth $5,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200
Previous 2,300
47.83%
Holding current value
$5,064
Previous $8,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
6Shares Held
36.4KCall Options Held
100Put Options Held
0-
Black Rock Inc. New York, NY27.5KShares$116,0620.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ7.58KShares$31,9960.0% of portfolio
-
Semmax Financial Advisors Inc. Winston Salem, NC153Shares$6450.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $48.8M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...